PMG-1015

N/A

Report date: 2026/04/08 16:01:22

Base Information

Drug NamePMG-1015
Drug Alias NamePMG-1015
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAmphiregulin modulators
TargetsAmphiregulin
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesPulmongene (Beijing) Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesPulmongene (Beijing) Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A